Antidiabetic effect of Glycyrrhizin glabra extract and Glycyrrhiza glabra Silver nanoparticle in female rats

Authors

  • Luma W Khaleel College of Veterinary Medicine, University of Baghdad, Baghdad, Iraq
  • Abdulrahman A Abdulhamed College of Veterinary Medicine, University of Baghdad, Baghdad, Iraq

DOI:

https://doi.org/10.60988/p.v36i3.20

Keywords:

Diabetes mellitus, Glycyrrhiza glabra, Silver nanoparticle, Alloxan, Nicotinamide

Abstract

Objective: To study the antidiabetic effect of Glycyrrhiza glabra ethanolic extract and Glycyrrhiza glabra Silver nanoparticle against induced Diabetes mellitus (D.M) by alloxan and nicotinamide in adult female Rats. Methods: The current study was performed on 36 d in which the G. glabra extract (40 mg/ Kg) and G. glabra extract loaded on Silver nanoparticle (40 mg/ Kg) were given to alloxan and nicotinamide (150mg/kg, 50 mg/kg respectively at single dose I.P.) induced diabetic rats. The antidiabetic effect has been evaluated biochemically. Results: The results of induction of D.M for 36 days showed a significant increase (P˂0.05) in serum Glucose concentration with a significant decrease (P˂0.05) in serum insulin concentration in D.M induced (G2) group when compared with the control group (G1). and showed a significant decrease (P˂0.05) in the serum glucose concentration and a significant increase (P˂0.05) of serum insulin concentration in (G3) group (received G. glabra extract) and (G4) group (G.glabra loaded on silver nanoparticle) in comparison with G2. Conclusion: This study concluded that Glycyrriza glabra extract and Glycyrrhiza glabra Silver nanoparticle have a significant antidiabetic effect induced by alloxan and nicotinamide.

References

Oguntibeju O.O. Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. Int. J. Physiol. Pathophysiol. Pharmacol. 11(3), 45, 2019.

Padhi S., Nayak A.K., Behera A. Type II diabetes mellitus: a review on recent drug based therapeutics. Biomed. Pharmacother. 131, 110708,.2020.

Martín-Timón I., Sevillano-Collantes C., Segura-Galindo A., del Cañizo-Gómez F.J. Type 2 diabetes and cardiovascular disease: have all risk factors the same strength?. World J Diabetes. 5(4), 444, 2014.

Nikiforov N.G., Wetzker R., Kubekina M.V., Petukhova A.V., Kirichenko T.V., Orekhov A.N. Trained circulating monocytes in atherosclerosis: ex vivo model approach. Front. pharmacol.10, 725, 2019.‏

Poznyak A.V., Wu W.K., Melnichenko A.A., Wetzker R., Sukhorukov V., Markin, A.M., Orekhov A.N. Signaling pathways and key genes involved in regulation of foam cell formation in atherosclerosis. Cells. 9(3), 584, 2020.

Kirichenko T.V., Myasoedova V.A., Sobenin I.A., Orekhov A.N. Phytotherapy for the prevention of atherosclerosis-associated early cerebral ischemia. Curr. Drug Metab. 19(5), 408-413, 2018.

Kirichenko T.V., Sukhorukov V.N., Markin A.M., Nikiforov N.G., Liu P.Y., Sobenin I. A., Aliev G. Medicinal plants as a potential and successful treatment option in the context of atherosclerosis. Front. pharmacol.11, 403, 2020.

Kao T.C., Wu C.H., Yen G.C. Bioactivity and potential health benefits of licorice. J. Agric. Food Chem. 62(3), 542-553, 2014.

Jiang M., Zhao S., Yang S., Lin X., He X., Wei X., Zhang Z. An “essential herbal medicine”—Licorice: A review of phytochemicals and its effects in combination preparations. J. Ethnopharmacol. 249, 112439, 2020.

Yang R., Wang L.Q., Yuan B.C., Liu Y. The pharmacological activities of licorice. Planta medica. 81(18), 1654-1669, 2015.

Markina Y.V., Kirichenko T.V., Markin A.M., Yudina I.Y., Starodubova A.V., Sobenin I.A., Orekhov A.N. Atheroprotective Effects of Glycyrrhiza glabra L. Molecules. 27(15), 4697, 2022.

Abdirahman Y.A., Juma K.K., Mukundi M.J., Gitahi S.M., Agyirifo D.S., Ngugi M.P., Njagi E.N.M. In-vivo antidiabetic activity and safety of the aqueous stem bark extract of Kleinia squarrosa. J Diabetes Metab. 6(9)1000601. 2015, 2015.

Rani R., Dahiya S., Dhingra D., Dilbaghi N., Kim K.H., Kumar S. Evaluation of anti-diabetic activity of glycyrrhizin-loaded nanoparticles in nicotinamide-streptozotocin-induced diabetic rats. Eur. J. Pharm. Sci.106, 220-230, 2017.

Boye A., Barku V.Y.A., Acheampong D.O., Ofori E.G. Abrus precatorius leaf extract reverses alloxan/nicotinamide-induced diabetes mellitus in rats through hormonal (insulin, GLP-1, and glucagon) and enzymatic (α-amylase/α-glucosidase) modulation. Biomed Res. Int. 2021.

Ko B.S., Jang J.S., Hong S.M., Sung S.R., Lee J.E., Lee M.Y., Park S. Changes in components, glycyrrhizin and glycyrrhetinic acid, in raw Glycyrrhiza uralensis Fisch, modify insulin sensitizing and insulinotropic actions. Biosci. Biotechnol. Biochem.71(6), 1452-1461, 2007

Sen S., Roy M., Chakraborti A.S. Ameliorative effects of glycyrrhizin on streptozotocin-induced diabetes in rats. J. Pharm. Pharmacol. 63(2), 287-296, 2011.

Semaan D.G., Igoli J.O., Young L., Marrero E., Gray A.I., Rowan E.G. In vitro anti-diabetic activity of flavonoids and pheophytins from Allophylus cominia Sw. on PTP1B, DPPIV, alpha-glucosidase and alpha-amylase enzymes. J. Ethnopharmacol. 203, 39-46, 2017.

Qian Y., Zheng Y., Jin J., Wu X., Xu K., Dai M., Shen J. Immunoregulation in diabetic wound repair with a photoenhanced glycyrrhizic acid hydrogel scaffold. Adv Mater. 34(29), 2200521, 2022.

Sasaki N., Ozono R., Higashi Y., Maeda R., Kihara Y. Association of insulin resistance, plasma glucose level, and serum insulin level with hypertension in a population with different stages of impaired glucose metabolism. J. Am. Heart Assoc. 9(7), e015546, 2020.

Yaas A.A., Al-Shakour A.A., Mansour A.A. Assessment of Serum Level of Protein Carbonyl as a Marker of Protein Oxidation in Patients with Type 2 Diabetes Mellitus. Al-Kindy Col. Med. J. 18(3), 190-195, 2022.

‏Cheng H.S., Yaw H. P., Ton S.H., Choy S.M., Kong J.M.X.F., Kadir K. Glycyrrhizic acid prevents high calorie diet− induced metabolic aberrations despite the suppression of peroxisome proliferator-activated receptor γ expression. Nutrition. 32(9), 995-1001, 2016.

Boucher J., Kleinridders A., Kahn C. R. Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb. Perspect. Biol. 6(1), a009191, 2014.

Sesti G., Federici M., Hribal M. L., Lauro D., Sbraccia P., Lauro R. Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. The FASEB Journal. 15(12), 2099-2111, 2001.

El-Magd N.F.A., El-Mesery M., El-Karef A., El-Shishtawy M.M. Glycyrrhizin ameliorates high fat diet-induced obesity in rats by activating NrF2 pathway. Life Sci. 193, 159-170, 2018.

Sun X., Duan X., Wang C., Liu Z., Sun P., Huo X., Meng Q. Protective effects of glycyrrhizic acid against non-alcoholic fatty liver disease in mice. Eur. J. Pharmacol. 806, 75-82, 2017.

Hanady J.M. Barriers to dietary compliance among diabetic patients. Iraqi Nat J Nur Spec. 21 (3): 19-26,‏ 2008.

Faiq M., Saleh E.S., Fathalla O.B. High Serum High Mobility Group A1 (HMGA1) Levels are associated with presence of Metabolic Syndrome: Case-control study. J Fac Med Baghdad. 65(1), 2023.

Seong S.H., Nguyen D.H., Wagle A., Woo M.H., Jung H.A., Choi J.S. Experimental and computational study to reveal the potential of non-polar constituents from Hizikia fusiformis as dual protein tyrosine phosphatase 1B and α-glucosidase inhibitors. Mar Drugs.17(5), 302, 2019.

Hamed Z.S., Abed R.R., Almashhadany M.S., Merkhan M.M. Effects of Hypericum perforatum on serum lipid vascular systems in mice. Iraqi J. Vet. Sci. 36(2), 525-530, 2022.

Hadi L.I., Al-saadi M.J. Effect of Dietary Supplementation of Rhus coriaria Grind Seeds and‎ Exogenous Fibrolytic Enzymes on Some Blood Lipids and Ruminal‎ Fermentation Parameters‎ of Awassi Male Lambs. Iraqi J. Vet. Med. 46(1), 30-38, 2022.

AL-Dujaily A.H., Mahmood A.K. Evaluation of Antibacterial and Antibiofilm Activity of Biogenic Silver Nanoparticles and Gentamicin Against Staphylococcus aureus Isolated from Caprine Mastitis. Iraqi J. Vet. Med. 46(1), 10-16, 2022.

Zhang Y., Yang S., Zhang M., Wang Z., He X., Hou Y., Bai G. Glycyrrhetinic acid improves insulin-response pathway by regulating the balance between the Ras/MAPK and PI3K/Akt pathways. Nutrients. 11(3), 604, 2019.

Walke P.B., Bansode S.B., More N.P., Chaurasiya A.H., Joshi R.S., Kulkarni, M.J. Molecular investigation of glycated insulin-induced insulin resistance via insulin signaling and AGE-RAGE axis. Biochim Biophys Acta Mol Basis Dis. 1867(2), 166029, 2021.

Khitam S.S., Alhtheal E.D., Azhar, J.B. Effect of Zinc Oxide nanoparticals preparation from Zinc Sulphate (ZnSo4) against gram negative or gram positive microorganisms in vitro. Iraqi J. Vet. Med. 42(1), 18-22, 2018.

Chia Y.Y., Liong S.Y., Ton S.H., bin Abdul Kadir K. Amelioration of glucose homeostasis by glycyrrhizic acid through gluconeogenesis rate-limiting enzymes. Eur. J. Pharmacol. 677(1-3), 197-202, 2012.

Rani R., Dahiya S., Dhingra D., Dilbaghi N., Kim K.H., Kumar S. Evaluation of anti-diabetic activity of glycyrrhizin-loaded nanoparticles in nicotinamide-streptozotocin-induced diabetic rats. Eur. J. Pharm. Sci.106, 220-230, 2017.

Ali Z.S., Khudair K.K. Synthesis, characterization of silver nanoparticles using Nigella sativa seeds and study their effects on the serum lipid profile and DNA damage on the rats’ blood treated with Hydrogen peroxide. Iraqi J. Vet. Med. 43(2), 23-37, 2019.

Nugroho A.K., Kusumorini N., Pramono S., Martien R. An update on Nanoparticle Formulation Design of Piperine to Improve its Oral bioavailability: A Review. Iraqi J. Pharm. Sci. 32(1), 14-30, 2023.

Downloads

Published

14-10-2024

Issue

Section

Research Articles